Serum Sickness Following Rituximab Therapy in a Patient with Pemphigus
Vulgaris: A Case Report
Serum sickness, a reaction presenting with a classic triad (fever, rash,
myalgia/arthralgia) and considered as a rare adverse event following
monoclonal antibodies and specifically following treatment with
rituximab. This report describes a case of serum sickness in a newly
treated young male patient with rituximab for pemphigus vulgaris.